Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Economic evaluation of Aclasta (TM) (zoledronic...
Conference

Economic evaluation of Aclasta (TM) (zoledronic acid 5 mg) versus Actonel (TM) (risedronate) in treatment of Paget's disease

Authors

Mittmann N; Isogai PK; Adachi JD; Kindundu CM; Barbeau M

Volume

17

Pagination

pp. S38-S39

Publisher

SPRINGER LONDON LTD

Publication Date

March 1, 2006

Name of conference

11th Conference of the National-Osteoporosis-Society

Conference place

Harrogate, ENGLAND

Conference start date

June 25, 2006

Conference end date

June 28, 2006

Conference proceedings

OSTEOPOROSIS INTERNATIONAL

ISSN

0937-941X

Labels